Are Testosterone Pellets Safe for Women? What the Evidence Actually Shows

Are testosterone pellets safe for women? Leading medical guidance — including ACOG, ISSWSH, and the international consensus statement signed by 11 societies — does not recommend testosterone pellets as a routine choice for women. No testosterone pellet is FDA-approved for women, the dose can't be adjusted after it's placed, and long-term safety data is limited. When testosterone is appropriate, guidelines prefer adjustable options you can stop.

Here's the part a lot of clinics won't say out loud: the bigger problem usually isn't testosterone — it's the pellet. Once it's under your skin, you can't dial the dose down, and you can't count on getting it back out. That one fact shapes the whole decision, and it's a big reason the major guidelines line up the way they do. Below, we'll show you what the evidence actually says, which side effects can't be undone, what to do if you already have one, and the better-controlled paths if you still want help.

Is this page for you?

The short answer: are testosterone pellets safe for women?

Testosterone pellets are not recommended for women as a routine choice by leading medical guidance. Testosterone itself has one well-supported use in women — treating low sexual desire after menopause that causes real distress. But the pellet is the sticking point: it can push hormone levels above the normal female range, the dose can't be lowered or stopped once it's in, and the long-term safety research is thin. When testosterone is the right call, guidelines point to a low-dose cream or gel with blood checks — not a pellet.

A "pellet" here means a tiny implant, about the size of a grain of rice, slipped under the skin (usually near the hip) during a quick in-office procedure. It slowly releases testosterone for roughly three to six months, then dissolves. Hold onto that last part — it matters more than anything else on this page.

Three questions that get blurred together (and shouldn't)

Most pages, and most sales pitches, mash three separate questions into one. Pull them apart and the whole topic gets clearer. We use this frame — call it The HRT Index decision frame — on every testosterone page we publish:

1. Can testosterone ever help women? Yes — for one specific thing, with decent evidence.
2. Do you have an evidence-backed reason to use it? That depends on a real assessment of your symptoms — not a single lab number.
3. Is a pellet the best-controlled way to deliver it? No. This is where pellets fall down.

A clinic can answer "yes" to question one and use that first yes to wave you toward a "yes" on question three. Don't let it. They're not the same decision.

What leading guidelines say about testosterone pellets for women

The major bodies that issue guidance here — ACOG, the Endocrine Society, ISSWSH, and the 2019 international consensus statement — do not recommend testosterone pellets as a routine route for women. Their wording differs, and the pellet-specific stance is strongest in some than others, so we read each one directly. Here's what they actually say, with dates, so you can check us.

Pellets are still used in clinical practice despite that guidance. A 2025 review estimated they make up roughly 10–15% of testosterone prescriptions for women in the U.S. Popular isn't the same as recommended — or proven safe.

Are testosterone pellets FDA-approved for women?

No testosterone pellet is FDA-approved for women. There is one FDA-approved testosterone pellet — a product called Testopel — but it's approved for menwith low testosterone caused by a medical condition, not for women. Pellets marketed to women are usually compounded (mixed by a pharmacy and not FDA-approved as a finished product), or they're the male product used "off-label." Either way, no pellet has been approved by the FDA for use in women.

Two plain-language definitions, because this is where the confusing words live:

• FDA-approved means the finished product was reviewed by the FDA for a specific group of patients, with checks on safety, effectiveness, and manufacturing quality. There is currently no FDA-approved testosterone product of any kind for women in the U.S. (FDA, 2025)
• Off-labelmeans a clinician prescribes an FDA-approved product (like a male gel) for a use or patient the label doesn't list. That's legal and common — but it's not the same as FDA approval for women.
• Compounded means a pharmacy or outsourcing facility prepares the product for a clinical need. The FDA does notreview compounded drugs before they're sold for safety, effectiveness, or quality the way it reviews approved products. (FDA, Compounding Q&A)

This matters for one reason: "bioidentical" is not the same as "FDA-approved." "Bioidentical" only describes a hormone's chemical shape — that it matches what your body makes. It says nothing about whether the finished product was tested for purity, dose accuracy, or safety. A compounded pellet can be called "bioidentical" and still skip FDA review entirely.

Is testosterone itself bad for women — or is it the pellet?

Testosterone isn't categorically off-limits for women. The strongest evidence supports a small, carefully monitored, through-the-skin dose for women with low sexual desire after menopause that causes distress (doctors call it HSDD — hypoactive sexual desire disorder). What the evidence does not support is testosterone as a general fix for tiredness, weight, mood, memory, or "anti-aging." The hormone can help one specific thing. The pellet is a separate question — and it adds a problem you can't easily undo.

Here's our one honest catch: the route we'd point you toward isn't FDA-approved for women either. There is no testosterone product the FDA has approved specifically for women in the U.S. — not pellets, not gels, not creams. So when we say "more controllable," we don't mean "FDA-approved." We mean a route a clinician can lower or stop. And testosterone isn't magic. If you came hoping it would fix fatigue, drop weight, or turn back the clock, we won't sell you that — the evidence isn't there. But if low desire that genuinely bothers you is the real issue, then the difference between a cream you can stop and a pellet you can't is the whole ballgame. That's exactly why the guidelines lean the way they do.

One more important point about HSDD: HSDD isn't diagnosed from a lab result.It takes a real clinical assessment of ongoing low desire that causes distress — and ruling out other causes like depression, medications, pain during sex, sleep problems, and relationship stress. A "low" testosterone number on its own does not mean you have HSDD or need testosterone.

What testosterone is — and isn't — backed to treat in women

Source: Global Consensus Position Statement, 2019

Why are testosterone pellets harder to control than a cream or gel?

The core pellet problem is the delivery system: you can't titrate it. A pellet keeps releasing testosterone for months, and some studies show it can spike levels above the normal female range early on, with big swings from person to person. A cream or gel is the opposite — a clinician can lower the dose or stop it under their direction, even though that doesn't make absorbed medication or existing effects vanish the same day. No testosterone route is automatically safe for every woman. But adjustability is a real, practical advantage.

Some numbers so this isn't hand-wavy. A 2025 review cites a rough postmenopausal range of about 10 to 55 ng/dL for women, and notes that historical pellet studies have shown early peaks above 100 to 250 ng/dL. "Supraphysiologic" is the medical word for levels above the normal female range, and that overshoot is the main driver of the side effects below.

Note on the patch: a testosterone patch was studied historically, but the only U.S. supplier discontinued it in 2023, so no testosterone patch is currently available here. MedlinePlus. "FDA-approved for women" is "No" across the board because there's no FDA-approved testosterone product for women in the U.S. — the gel is preferred because it's adjustable, not because it carries an FDA stamp for this use.

Testosterone pellet side effects in women — and which ones may be permanent

Most testosterone side effects in women come from levels running too high — which pellets are prone to do. Many effects ease off when levels come down. But with a pellet you can't bring them down quickly, so a side effect can stick around for months. And a few effects may be permanent — which is why the control problem matters so much. Here's the honest breakdown, with how strong the evidence is for each (ACOG, 2023):

We're spelling out the permanent ones on purpose. ACOG and other guidance warn that the high levels pellets can cause may lead to lasting changes — voice deepening and clitoral enlargement among them. Combine a prolonged delivery method you can't stop on demand with effects that may be irreversible, and you can see why the guidelines steer women elsewhere.

If you already have a pellet and you're seeing any of the "report right away" signs, skip to what to do now.

What the research shows as of June 2026

The research doesn't give pellets a clean bill of health — it mostly shows how thin and mixed the evidence still is. The best summary to date found very few high-quality studies, some favorable but low-quality signals, and no way to confirm long-term safety. Some women clearly feel better, and that signal belongs in the record — but "some people feel better" and "this is proven safe" are different sentences.

The honest read: a small clinic study can find reassuring results for a few measures (like Hernandez 2025) while the overall evidence base stays too weak to call pellets a routinely safe first choice. Both things are true. They're answering different questions.

Can you fix it if a pellet dose runs too high?

Not easily — that's the heart of the problem. A testosterone pellet isn't designed for routine removal or dose changes. A clinician may sometimes assess whether a removal procedure is even possible in a specific case, but you can't count on prompt removal, and medication your body has already absorbed can't be taken back. There's no reliable "undo." If a level runs high, symptoms and lab results have to be sorted out by a clinician using the right test — and then, largely, waited out.

So if you're noticing new acne, hair changes, a voice change, a genital change, mood shifts, or new bleeding after a pellet, that's a reason to call the clinician who placed it — not a reason to panic, and definitely not a reason to try anything at home. Do notcut, press, or massage the area to force a pellet out, and don't take another drug or supplement to "cancel" it without medical advice.

Already have a testosterone pellet? Here's what to do

If you already have a pellet and feel unwell, contact the clinician who placed it promptly — and bring the details: the product, the dose, the insertion date, and when your symptoms started. Don't try to remove it yourself, and don't self-treat with another hormone. Truly urgent symptoms need emergency care, not a web search.

First, take a breath. A lot of women land here scared, and that's understandable. Many reported effects can be evaluated and managed — though some changes may last, and the dose can't be stopped right away.

Save and bring this one-page record — it makes the appointment far more useful:

• Product name (and compounding pharmacy, if you know it)
• The stated dose, and which hormones were in the pellet
• Insertion date and where on your body
• Your symptoms and when they started
• Any "before" and "after" lab results
• Other medications and supplements you take
• Photos of any insertion-site changes

One more thing worth knowing: you or your clinician can report a bad reaction or a product problem to the FDA's MedWatch program. It's how safety signals get tracked, and it's your right to use it.

Who should pause before getting a testosterone pellet?

A pellet is a poor first step when the reason for it is unclear, the goal is general "optimization," the exact product or dose isn't disclosed, there's no monitoring plan, or you want a route you can adjust quickly. And some situations call for an in-person clinician first, not a pellet.

Pump the brakes before insertion if any of these are true:

• You're pregnant, could become pregnant, or are breastfeeding. ISSWSH specifically advises against testosterone for women who are or may become pregnant.
• No one has actually assessed whether your low desire meets the definition of HSDD.
• The pellet is being sold mainly for energy, weight, mood, memory, or anti-aging.
• The exact hormone, dose, and pharmacy aren't disclosed, or no one will tell you whether it's compounded or an FDA-approved male product used off-label.
• There's no baseline lab and no follow-up plan.
• The clinic can't clearly explain what happens if your level runs too high.
• You have a complex history — a hormone-sensitive cancer, significant heart or liver disease, unexplained bleeding, or major mood symptoms.
• You strongly prefer a treatment you can lower or stop. (With a pellet, you can't.)

More controllable, guideline-preferred alternatives to testosterone pellets

Your next path depends on the symptom you're actually trying to treat — and most women fit one of three buckets. None of these is "safe for everyone," and the long-term safety of testosterone in women isn't fully established by any route. But each gives you more control than a pellet.

If your real concern is low sexual desire after menopause (HSDD)

You now have two FDA-aware options to discuss:

• Low-dose, monitored transdermal testosterone (off-label). Guidelines describe cautious use of an FDA-approved male product at a small fraction of the male dose — often starting around a tenth — with the exact dose and a blood-testing plan set by the prescriber (ISSWSH, 2021). The testing is to screen for too-high levels — not to chase a target number or to diagnose HSDD. It's adjustable, which a pellet isn't. For a full breakdown, see our testosterone for women dosage guide.
• Flibanserin (Addyi), a non-hormonal daily pill. In December 2025 the FDA expanded Addyi's approval to include HSDD in women under 65, including those who are postmenopausal — making it the first and only FDA-approved medication for HSDD across that age range (FDA via Urology Times, Dec 2025). It's not a hormone and not interchangeable with testosterone, and it carries its own boxed warning (alcohol and certain liver conditions can cause a dangerous drop in blood pressure or fainting) plus side effects like dizziness and sleepiness. Worth asking about if HSDD is your issue.

If your main symptoms are hot flashes or night sweats

FDA-approved menopause hormone therapy is the best-studied option for those vasomotor symptoms, and non-hormonal options exist too. Sleep that's disrupted by night sweats often improves when the night sweats are treated; ongoing sleep or mood symptoms deserve a separate look. If your issue is vaginal dryness or painful sex, low-dose local vaginal treatment is usually the more targeted choice.

If you're not sure which bucket you're in

That's exactly what a structured intake is for.

What to ask before you pay for a testosterone pellet

A clinic worth trusting can explain why it's recommending a fixed, long-acting route, checks the right baseline and follow-up labs, tells you the exact product and whether it's FDA-approved or compounded, and gives you a real plan if your level runs high. Copy or screenshot this list and bring it — it's the fastest way to separate a careful clinic from a sales pitch.

Your before-you-pay checklist:

1. What exact symptom or diagnosis are we treating?
2. Have you ruled out other causes of it?
3. Why testosterone — and why for me?
4. Why a pellet instead of a route I can adjust or stop?
5. What exactly goes in the pellet, and at what dose?
6. Is the exact pellet an FDA-approved male product used off-label, or a compounded product? (No pellet is FDA-approved for women.)
7. If compounded, which pharmacy makes it, and what quality info can I see?
8. How will you use labs to screen for too-high levels — and which test and reference range will you use?
9. When will you re-check my symptoms and labs?
10. Exactly what will you do if my level comes back too high?
11. What's the total cost — insertion, labs, follow-ups, re-insertions, treating complications?
12. What's the one alternative that gives me the most control?

Did the FDA's 2026 hormone-therapy changes approve testosterone pellets for women?

No. On February 12, 2026, the FDA approved labeling changes to six menopausal hormone therapy products and removed the boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia (FDA, Feb 2026). That was big news — but those were estrogen and progestogenmenopause products (like Prometrium, Divigel, and Bijuva). The change did not approve a testosterone product for women, and it did not change the status of testosterone pellets. If you saw the headlines about the FDA "easing" hormone-therapy warnings, they're about estrogen-based menopause therapy — a different decision from the pellet question.

How we researched this — The HRT Index Verification Standard

We built this page by reviewing primary regulatory and guideline sources, peer-reviewed studies, and a few expert reviews — not by rewriting other blogs. Our review framework is The HRT Index Verification Standard: read the actual documents, keep FDA-approved and compounded options strictly separate, trace every claim to a dated source, and re-check on a fixed schedule.

The HRT Index judges providers on five things, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We applied that same discipline here — to the evidence, the regulatory status, and the dates.

This is editorial research, written to help you make a smart next decision. It is not a medical consultation, and it doesn't replace advice from a clinician who knows your history.

Frequently asked questions

Still not sure which HRT program is right for you?

Sources

1. ACOG. Compounded Bioidentical Menopausal Hormone Therapy, Clinical Consensus No. 6, November 2023. acog.org
2. Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab, 2019 (endorsed by 11 societies, including the Endocrine Society, the International Menopause Society, ISSWSH, and The Menopause Society). pmc.ncbi.nlm.nih.gov
3. Parish SJ, et al. ISSWSH Clinical Practice Guideline / Process of Care for the Use of Systemic Testosterone for HSDD in Women. J Sex Med, 2021. isswsh.org
4. The Menopause Society. 2022 Hormone Therapy Position Statement. menopausejournal.com
5. Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes (structured narrative review). Cureus / PMC, 2025. pmc.ncbi.nlm.nih.gov
6. Jiang X, et al. Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in postmenopausal women. Menopause, 2021;28(8) (539 women; 57.6% vs 14.8% side-effect rate). pubmed.ncbi.nlm.nih.gov
7. Hernandez BS, et al. Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile. Transl Androl Urol, 2025;14(7). pubmed.ncbi.nlm.nih.gov
8. U.S. FDA. Testopel (testosterone pellets) Prescribing Information (approved for males with hypogonadism; Schedule III).
9. U.S. FDA. Class-Wide Labeling Changes for Testosterone Products, February 28, 2025; Labeling Changes to Menopausal Hormone Therapy Products, February 12, 2026. fda.gov
10. U.S. FDA. Human Drug Compounding: Q&A. fda.gov
11. MedlinePlus. Testosterone Transdermal Patch (discontinued in the U.S.). medlineplus.gov
12. FDA expanded approval of flibanserin (Addyi) for HSDD in women under 65, December 2025 (Sprout Pharmaceuticals; reported via Urology Times and Contemporary OB/GYN). urologytimes.com
13. DEA. Drug Scheduling (testosterone is Schedule III). dea.gov